Evidence map›Paper›PMID 37324754›Full record

ArticleJournal of arrhythmia2023

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy.

Tadafumi Nanbu, Akihiko Yotsukura, George Suzuki, Hiroyuki Takekawa, Yuki Tanaka, Katsuma Yamanashi, Masaya Tsuda, Izumi Yoshida, Masayuki Sakurai, Takashi Ashihara

Open access · goldAbstract read
In one paragraph

Article in Journal of arrhythmia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tadafumi NanbuDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.ORCID https://orcid.org/0000-0002-7590-5029
Akihiko YotsukuraDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
George SuzukiDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Hiroyuki TakekawaDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Yuki TanakaDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Katsuma YamanashiDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Masaya TsudaDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Izumi YoshidaDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Masayuki SakuraiDepartment of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Takashi AshiharaDepartment of Medical Informatics and Biomedical Engineering Shiga University of Medical Science Seta Tsukinowa-cho, Otsu Japan.
Hokko Memorial Hospital · JPShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rotors are the source of atrial fibrillation (AF). However, the ablation of rotors for persistent AF is challenging. The purpose of this study was to identify the dominant rotor by accelerating the organization of AF using a sodium channel blocker and detecting the rotor's preferential area that governs AF. Methods: Overall, 30 consecutive patients with persistent AF who underwent pulmonary vein isolation and still sustained AF were enrolled. Pilsicainide 50 mg was administered. An online real-time phase mapping system (ExTRa Mapping™) was used to identify the meandering rotors and multiple wavelets in 11 left atrial segments. The time ratio of non-passive activation (%NP) was evaluated as the frequency of rotor activity in each segment. Results: Conduction velocity became slower-from 0.46 ± 0.14 to 0.35 ± 0.14 mm/ms ( Conclusions: A sodium channel blocker organized persistent AF. In selective patients with a wide organized area, high %NP area ablation could convert AF into atrial tachycardia or terminate AF.

Indexed as

ablationatrial fibrillationrotorssodium channel blocker

Identifiers

PMID37324754
PMCPMC10264751
OpenAlexW4362464343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.